The reason for the slightly higher cut-off values in the current cohort compared to previous ones was interpreted as the higher frequencies of aPL positivity, hypertension, and hyperlipidemia in the present patient population compared to previous cohorts [8,10,12–14]. The gene discussed is FASLG; the disease is hyperlipidemia.